MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ProMetic Life Sciences Company Profile (TSE:PLI)

Consensus Ratings for ProMetic Life Sciences (TSE:PLI) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: C$4.81

Analysts' Ratings History for ProMetic Life Sciences (TSE:PLI)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016RBC CapitalReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016National Bank FinancialReiterated RatingOutperform Market WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Paradigm CapitalBoost Price TargetBuyC$2.90 -> C$3.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016CIBCInitiated CoverageSector OutperformerC$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Panmure GordonBoost Price TargetBuyC$6.70View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015ScotiabankBoost Price TargetOutperformC$3.50 -> C$4.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Canaccord GenuityBoost Price TargetBuyC$4.25 -> C$4.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/3/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha